Charles J. Casamento - 31 Aug 2023 Form 4 Insider Report for First Wave BioPharma, Inc. (ENTO)

Role: Director
Signature: /s/ Charles Casamento
Issuer symbol: ENTO
Transactions as of: 31 Aug 2023
Net transactions value: -$1,816
Form type: 4
Filing time: 05 Sep 2023, 20:08:53 UTC
Previous filing: 21 Jun 2023
Next filing: 18 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FWBI	Common Stock	Sale	$1,816	-6,053	-50%	$0.3000	6,108	31 Aug 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3001 to $0.3013. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	Includes unvested RSUs.

Content

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3001 to $0.3013. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes unvested RSUs.